ASPIRE envisions to create an inclusive and enabling resource platform for budding entrepreneurs in diverse science and technology fields. Its mission statement is to enhance and deepen the incubation activities and knowledge enterprise initiatives at UoH and thereby create a vibrant entrepreneurial eco-system on the campus. Currently, there are 3 incubation centres (ICs) functioning under ASPIRE, i.e., ASPIRE-BioNEST, ASPIRE-TBI, and ASPIRE TIDE, providing incubation support in the areas of Life Sciences, Pharma & chemistry as well as materials and IT & Electronics, respectively.  TBI was established with the support of DST, TIDE supported by DietY and the BioNEST was established with support from BIRAC/DBT. These ICs are equipped with state-of-the-art infrastructure and necessary instrumentation.

The ICs are spread over 50000 sqft, with excellent infrastructure and plug-and-play state-of-the-art lab suites. Put together the three ICs shall cover almost all the major areas of research and provide ample opportunities for the budding entrepreneurs emerging from the campus as well as from surrounding region. Since the beginning, the ICs together have supported more than 80 start-ups and helped them to translate their ideas into technologies. At least 5 of the graduated companies have entered the market space and generated more than 5 cr revenues each. The ICs created nearly 300 jobs, supported the filing of 20+ patents and enabled the development of >15 products, while a few more are in the pipeline. In its recent foundation day celebrations on 12^th March 2022, 2 new products developed by M/s 30 M Genomics (Rapid, portable and inexpensive PCR) and M/s Grus & Grade (Upajguru, a Block chain based platform for farmers) were launched by Dr. Krishna Ella CMD, Bharath Biotech and Dr. S. Chandrasekhar Hon. Secretary, DST, Govt. of India, respectively. One investment was formalized into a start-up M/s UR Advanced Therapeutics by the promoters of GVK Bio and agreements were exchanged on the same day. Two technologies developed by a start-up M/s Reagene Innovations on Covid19 diagnostics were transferred to an US based pharma company M/s Lay Science Inc. for scale-up and marketing. One technology on Biotherapeutics and one technology on Pharma intermediate enzymes developed by M/s Bycus Therapeutics was transferred to another Biotech company M/s GeneSys Biologics for scaling up and marketing. The excellent all round growth of ASPIRE-BioNEST has enabled it to bag the “Best Emerging Bioincubator in the country” honour for the year 2021.

In order to increase the participation of students, researchers, and faculty in the innovation and entrepreneurship activities, ASPIRE started pre incubation program through a concept competition exclusively for UoH community. Pre incubation program not only creates awareness among the fraternity about entrepreneurship but also enables the students and researchers to have the first-hand experience.  Under this program, the selected candidates shall be provided incubation space along with limited consumables & chemicals free of cost to implement their idea. The executing team also gets technical and business mentoring support from experienced mentors, besides free access to all the common instrumentation facilities at the ICs. They also get benefited from all the training programs and conferences which are being conducted periodically. Upon completion of the tenure, the successful ideas will be nurtured further to participate in the funding challenges organized by different government bodies and private venture capitalists for taking it to the next level.

Expanding on this concept, ASPIRE now proposes to train the youth of socially disadvantaged groups in entrepreneurial capabilities.